The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects - PubMed (original) (raw)

Comparative Study

The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects

Marzia Fanelli et al. Dis Markers. 2005.

Abstract

Among the putative candidate genes for insulin resistance, the peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) is a transcriptional coactivator of PPARgamma and alpha, regulating a wide range of processes involved in energy production and utilization, such as thermogenesis, liver gluconeogenesis, glucose uptake in muscle. In population studies a Gly482Ser substitution in PGC-1alpha has been reported to be associated with increased risk of type diabetes 2 and insulin resistance. In the present study we have analysed the association between the Gly482Ser missense mutation of the PGC-1alpha gene and insulin sensitivity and glucose tolerance in a population of obese non-diabetic subjects. The Gly482Ser SNPs was detected by PCR-RFLP in a cohort of 358 Caucasian obese subjects (223 with normal glucose tolerance (NGT) and 125 with impaired glucose tolerance (IGT). We observed a significant association (p <0.007) between carriers of the Gly482Ser variant of the PGC-1alpha gene and insulin resistance measured by HOMAIR. Multivariate analysis confirmed that the Gly482Ser SNP was a significant (p < 0.02) determinant of decreased insulin sensitivity, independently from other well-known modulators of insulin action. In conclusion, we have found significant association between the Gly482Ser variant of the PGC-1alpha gene and reduced insulin sensitivity in obese subjects. This association resulted independent from all other known modulators of insulin resistance, and suggests a primary role for the PGC-1alpha gene on the genetic susceptibility to insulin resistance in obesity.

PubMed Disclaimer

Cited by

Effects of PPARG and PPARGC1A gene polymorphisms on obesity markers.
Muntean C, Sasaran MO, Crisan A, Banescu C. Muntean C, et al. Front Public Health. 2022 Nov 16;10:962852. doi: 10.3389/fpubh.2022.962852. eCollection 2022. Front Public Health. 2022. PMID: 36466447 Free PMC article.
Computational Analysis of Gly482Ser Single-Nucleotide Polymorphism in PPARGC1A Gene Associated with CAD, NAFLD, T2DM, Obesity, Hypertension, and Metabolic Diseases.
Taghvaei S, Saremi L, Babaniamansour S. Taghvaei S, et al. PPAR Res. 2021 Aug 5;2021:5544233. doi: 10.1155/2021/5544233. eCollection 2021. PPAR Res. 2021. PMID: 34394332 Free PMC article.
Polycystic ovary syndrome and mitochondrial dysfunction.
Zhang J, Bao Y, Zhou X, Zheng L. Zhang J, et al. Reprod Biol Endocrinol. 2019 Aug 16;17(1):67. doi: 10.1186/s12958-019-0509-4. Reprod Biol Endocrinol. 2019. PMID: 31420039 Free PMC article. Review.
THE PPARGC1A - GLY482SER POLYMORPHISM (RS8192678) AND THE METABOLIC SYNDROME IN A CENTRAL ROMANIAN POPULATION.
Csép K, Szigeti E, Vitai M, Korányi L. Csép K, et al. Acta Endocrinol (Buchar). 2017 Apr-Jun;13(2):161-167. doi: 10.4183/aeb.2017.161. Acta Endocrinol (Buchar). 2017. PMID: 31149168 Free PMC article.
Systematic Meta-analysis Revealed an Association of PGC-1_α_ rs8192678 Polymorphism in Type 2 Diabetes Mellitus.
Xia W, Chen N, Peng W, Jia X, Yu Y, Wu X, Gao H. Xia W, et al. Dis Markers. 2019 Mar 3;2019:2970401. doi: 10.1155/2019/2970401. eCollection 2019. Dis Markers. 2019. PMID: 30944665 Free PMC article.

The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects - PubMed (original) (raw)